T cell response against SARS-CoV-2 persists after one year in patients surviving severe COVID-19

BACKGROUND: In critically ill COVID-19 patients, the initial response to SARS-CoV-2 infection is characterized by major immune dysfunctions. The capacity of these severe patients to mount a robust and persistent SARS-CoV-2 specific T cell response despite the presence of severe immune alterations du...

Descripción completa

Detalles Bibliográficos
Autores principales: Venet, Fabienne, Gossez, Morgane, Bidar, Frank, Bodinier, Maxime, Coudereau, Rémy, Lukaszewicz, Anne-Claire, Tardiveau, Claire, Brengel-Pesce, Karen, Cheynet, Valérie, Cazalis, Marie-Angélique, Pescarmona, Rémi, Garnier, Lorna, Ortillon, Marine, Buisson, Marielle, Bouscambert-Duchamp, Maude, Morfin-Sherpa, Florence, Casalegno, Jean-Sébastien, Conti, Filippo, Rimmelé, Thomas, Argaud, Laurent, Cour, Martin, Saadatian-Elahi, Mitra, Henaff, Laetitia, Vanhems, Philippe, Monneret, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957405/
https://www.ncbi.nlm.nih.gov/pubmed/35349827
http://dx.doi.org/10.1016/j.ebiom.2022.103967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957405/
https://www.ncbi.nlm.nih.gov/pubmed/35349827
http://dx.doi.org/10.1016/j.ebiom.2022.103967

Ejemplares similares